# AXITINIB
> **ANDA210234** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS · Approved 2018-08-07
## Drug
- **FDA Application Number:** ANDA210234
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AXITINIB
- **Generic name:** Axitinib
- **Active ingredients:** AXITINIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** TEVA PHARMS
- **First approval:** 2018-08-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210234)
---
*MORVS · CC0 1.0*